Drugs / Oligo Fucoidan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06959966 | Aug 2019 → Dec 2022 | leiomyoma | Taipei Medical University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oligo-Fucoidan | “Oligo-Fucoidan capsule, 4 grams per day (two capsules), taken orally for six months.” NCT06959966 ↗ |
| Modality | Other / unclassified | “a commercially available dietary supplement” NCT06959966 ↗ |
| Route | Oral | “taken orally” NCT06959966 ↗ |